Skip to main content

Table 1 Characteristics of the studied women (n = 110)

From: Inflammatory markers and cardiovascular risks among overweight-obese Emirati women

Demographics and medical history [number (percentage) of patients]
 Age, mean ± SD, years 39 ± 9 (median 36, range 30–65)
 Education
  Primary 28 (25)
  Secondary 38 (35)
  University 44 (40)
 Marital status
  Married 81 (74)
  Single 18 (16)
  Divorced 11 (10)
 Occupation
  Housewife 72 (65)
  Employed 22 (20)
  History of dyslipidemia 8 (7)
  History of diabetes 7 (6)
  Polycystic ovary syndrome 9 (8)
  Self-physical activity ≥150 min/week 16 (15)
Anthropometrics, mean ± SD (median and range)
 Waist circumference (cm) 100 ± 13 (median 99, range 71–144)
 Hip circumference (cm) 116 ± 11 (median 116, range 49–148)
 Waist: hip ratio 0.86 ± 0.08 (median 0.86, range 0.63–1.11)
 Body mass index (kg/m2) 34 ± 6 (median 33, range 25–58)
 Weight (kg) 84 ± 14 (median 83, range 58–123)
 Systolic blood pressure (mmHg) 120 ± 13 (median 120, range 92–158)
 Diastolic blood pressure (mmHg) 73 ± 9 (median 73, range 53–100)
 Percent body fat 41 ± 5 (median 41, range 29–54)
 Percent fat-free muscle 47 ± 5 (median 46, range 36–64)
Laboratory biomarkers, mean ± SD (median and range)
 Fasting blood glucose (mmol/L) 5.5 ± 1.8 (median 5.1, range 3.9–19.4)
 Hemoglobin A1c (%) 5.8 ± 0.9 (median 5.7, range 4.5–12.0)
 Total cholesterol (mmol/L) 4.9 ± 0.9 (median 4.9, range 3.4–7.7)
 LDL cholesterol (mmol/L) 3.0 ± 0.7 (median 3.0, range 1.4–5.4)
 HDL cholesterol (mmol/L) 1.1 ± 0.3 (median 1.0, range 0.5–2.6)
 Triglyceride (mmol/L) 1.0 ± 0.4 (median 1.0, range 0.4–2.3)
 Adiponectin (µg/L) 6.5 ± 3.4 (median 5.4, range 1.1–18.4)
 hsCRP (mg/L) 7.8 ± 7.7 (median 5.4, range 0.2–51.3)
 IL-6 (pg/mL) 2.7 ± 2.1 (median 2.0, range 0.2–14.0)
 TNF-α (ng/L) 0.014 ± 0.04 (median 0.013, range 0.007–0.037)
 25-Hydroxyvitamin D (nmol/L) 21.6 ± 15.1 (median 17.0, range 5.0–91.0)
  1. LDL low-density lipoprotein, HDL high-density lipoprotein, hsCRP high sensitivity C-reactive protein, IL-6 interleukin-6, TNF-α tumor necrosis factor-alpha